ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,317.59
-0.26%
Dow Jones
39,069.59
0.01%
Gold vs US Dollar
2,334.20
0.00%
Brent Oil
81.965
0.00%
Bitcoin
68,978.78
-0.42%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Tevogen Bio Holdings Inc (TVGN) Share Price

TVGN Tevogen Bio Holdings Inc

0.82
0.00 (0.00%)
25 May 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Tevogen Bio Holdings Inc NASDAQ:TVGN NASDAQ Common Stock  Class A Ordinary Shares
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.00 0.00 0.82 0.82 0.835 0.8362 0.78 0.8362 127,383 04:00:05   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Biological Pds,ex Diagnstics  -67k -0.0004 -2050.00 135.65M
 Type  Size  Price  Time  Units 
 9 5 0.82 23:59:54 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore TVGN News
16/05/202419:00GLOBETevogen Bio Appoints Former Police Chief & FBI National Academy Graduate, William Keane, as Vice President of Strategic Initiatives
10/05/202422:40GLOBETevogen Bio Announces Up to $50 Million in Financing to Further Advance Operational Objectives
01/05/202413:05GLOBETevogen Bio Announces Full Year 2023 Financial Results and Upcoming Operational Objectives
26/04/202414:23GLOBETevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointments
11/04/202413:05GLOBETevogen Bio’s Chief Scientific Officer Speaks on the Harnessing of Cytotoxic T Lymphocytes (CTLs) to Target Cancers
03/04/202413:05GLOBETevogen Bio Appoints Tapan V Shah as Head of Investor Relations and Corporate Development
28/03/202412:05GLOBETevogen Bio Reports Series A-1 Preferred Stock Investment at $10 Conversion Price
Period
Draw mode
Data Downloads for TVGN

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Tevogen Bio Holdings Inc Articles